Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018

A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood

Guindon, S., & Gascuel, O. (2003) · Systematic Biology · doi:10.1080/10635150390235520 · Cited by 16,923

ClonalFrameML: Efficient Inference of Recombination in Whole Bacterial Genomes

Didelot, X., & Wilson, D. J. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004041 · Cited by 896

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

Eyre, D. W., Sanderson, N. D., Lord, E., Regisford-Reimmer, N., Chau, K., Barker, L., Morgan, M., Newnham, R. S., Golparian, D., Unemo, M., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.27.1800323 · Cited by 345

Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseriagonorrhoeae Strain

Lahra, M. M., Martin, I., Demczuk, W., Jennison, A. V., Lee, K.-I., Nakayama, S.-I., Lefebvre, B., Longtin, J., Ward, A., Mulvey, M. R., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2404.171873 · Cited by 239

New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan

Nakayama, S., Shimuta, K., Furubayashi, K., Kawahata, T., Unemo, M., & Ohnishi, M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00504-16 · Cited by 212

High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes

Chisholm, S., Dave, J., & ISON, C. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00309-10 · Cited by 193

Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains

Demczuk, W., Sidhu, S., Unemo, M., Whiley, D. M., Allen, V. G., Dillon, J. R., Cole, M. J., Seah, C., Trembizki, E., Trees, D. L., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00100-17 · Cited by 188

Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin

Whiley, D. M., Jennison, A. V., Pearson, J. C., & Lahra, M. M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30340-2 · Cited by 172

Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study

Silva, D. D., Peters, J. R., Cole, K., Cole, M. J., Cresswell, F. V., Dean, G. L., Dave, J., Thomas, D. R., Foster, K., Waldram, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30157-8 · Cited by 161

Gonorrhoea

Unemo, M., Seifert, H. S., Hook, E. W., Hawkes, S., Ndowa, F. J., & Dillon, J. R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0128-6 · Cited by 558

WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study

Unemo, M., Lahra, M. M., Escher, M., Eremin, S., Cole, M. J., Galarza, P., Ndowa, F., Martin, I., Dillon, J.-A. R., Galas, M., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00171-3 · Cited by 272

World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts

Unemo, M., Lahra, M. M., Cole, M., Galarza, P., Ndowa, F., Martin, I., Dillon, J.-A. R., Ramon-Pardo, P., Bolan, G., & Wi, T. (2019) · Sexual Health · doi:10.1071/sh19023 · Cited by 262

2020 European guideline for the diagnosis and treatment of gonorrhoea in adults

Unemo, M., Ross, J., Serwin, A. B., Gomberg, M. A., Cusini, M., & Jensen, J. S. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420949126 · Cited by 246

Antimicrobial treatment and resistance in sexually transmitted bacterial infections

Jensen, J. S., & Unemo, M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01023-3 · Cited by 139

A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch

Sánchez-Busó, L., Yeats, C., Taylor, B., Goater, R., Underwood, A. P., Abudahab, K., Argimón, S., Ma, K. C., Mortimer, T. D., Golparian, D., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00858-2 · Cited by 128

Emerging and Reemerging Sexually Transmitted Infections

Williamson, D. A., & Chen, M. Y. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1907194 · Cited by 117

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022

Pleininger, S., Indra, A., Golparian, D., Heger, F., Schindler, S., Jacobsson, S., Heidler, S., & Unemo, M. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.24.2200455 · Cited by 106

Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928–2013): antimicrobial use/misuse selects for resistance and drives evolution

Golparian, D., Harris, S. R., Sánchez-Busó, L., Hoffmann, S., Shafer, W. M., Bentley, S. D., Jensen, J. S., & Unemo, M. (2020) · BMC Genomics · doi:10.1186/s12864-020-6511-6 · Cited by 90

Neisseria gonorrhoeae Population Genomics: Use of the Gonococcal Core Genome to Improve Surveillance of Antimicrobial Resistance

Harrison, O. B., Cehovin, A., Skett, J., Jolley, K. A., Massari, P., Genco, C. A., Tang, C. M., & Maiden, M. C. J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa002 · Cited by 82

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions

Lin, E. Y., Adamson, P. C., & Klausner, J. D. (2021) · Drugs · doi:10.1007/s40265-021-01530-0 · Cited by 81

Antimicrobial resistance in sexually transmitted infections

Tien, V., Punjabi, C. D., & Holubar, M. K. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz101 · Cited by 75

High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinicalNeisseria gonorrhoeaeisolates from 25 European countries, 2018

Unemo, M., Ahlstrand, J., Sánchez-Busó, L., Day, M. J., Aanensen, D. M., Golparian, D., Jacobsson, S., Cole, M. J., the European Collaborative Group, Torreblanca, R. A., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab024 · Cited by 62

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis

Fifer, H., Doumith, M., Rubinstein, L., Mitchell, L., Wallis, M., Singh, S., Singh, G. K. J., Rayment, M., Evans-Jones, J., Blume, A., et al. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae369 · Cited by 59

Background review for the ‘2020 European guideline for the diagnosis and treatment of gonorrhoea in adults’

Unemo, M., Ross, J., Serwin, A. B., Gomberg, M. A., Cusini, M., & Jensen, J. S. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420948739 · Cited by 56

High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Ouk, V., Heng, L. S., Virak, M., Deng, S., Lahra, M. M., Frankson, R. M., Kreisel, K. M., McDonald, R., Escher, M., Unemo, M., et al. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae053 · Cited by 52

Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017–2018

Yuan, Q., Li, Y., Xiu, L., Zhang, C., Fu, Y., Jiang, C., Tang, L., & Peng, J. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1681242 · Cited by 52

Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023

Maubaret, C., Caméléna, F., Mrimèche, M., Braille, A., Liberge, M., Mainardis, M., Guillaume, C., Noël, F., Bébéar, C., Molina, J., et al. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.37.2300456 · Cited by 51

Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa

Maduna, L. D., Kock, M. M., van der Veer, B. M. J. W., Radebe, O., McIntyre, J. A., van Alphen, L. B., & Peters, R. P. H. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-20 · Cited by 51

Exploration of the Neisseria Resistome Reveals Resistance Mechanisms in Commensals That May Be Acquired by N. gonorrhoeae through Horizontal Gene Transfer

Fiore, M. A., Raisman, J. C., Wong, N. H., Hudson, A. O., & Wadsworth, C. B. (2020) · Antibiotics · doi:10.3390/antibiotics9100656 · Cited by 49

Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–16

Lan, P. T., Golparian, D., Ringlander, J., Hung, L. V., Thường, N. V., & Unemo, M. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa040 · Cited by 44

Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects

Golparian, D., & Unemo, M. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2015329 · Cited by 43

WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational study

Unemo, M., Lahra, M. M., Cole, M. J., Marcano, D., Jacobsson, S., Galarza, P. G., Martín, I., Kreisel, K. M., Galas, M., Bertagnolio, S., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101181 · Cited by 38

GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility

Golparian, D., Jacobsson, S., Sánchez-Busó, L., Bazzo, M. L., Lan, P. T., Galarza, P. G., Ohnishi, M., & Unemo, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac366 · Cited by 36

High precision Neisseria gonorrhoeae variant and antimicrobial resistance calling from metagenomic Nanopore sequencingPreprint

Sanderson, N. D., Swann, J., Barker, L., Kavanagh, J., Hoosdally, S., Crook, D. W., the GonFast Investigators Group, Street, T. L., & Eyre, D. W. (2020) · Genome Research · doi:10.1101/gr.262865.120 · Cited by 36

Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023

Caméléna, F., Mérimèche, M., Brousseau, J., Mainardis, M., Verger, P., Risbe, C. L., Brottet, É., Thabuis, A., Bébéar, C., Molina, J., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3009.240557 · Cited by 31

Australian Gonococcal Surveillance Programme annual report, 2014

Lahra, M. M., & Australian Gonococcal Surveillance Programme (2015) · Communicable Diseases Intelligence · doi:10.33321/cdi.2015.39.39 · Cited by 29

Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia

Fifer, H., Hughes, G., Whiley, D. M., & Lahra, M. M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30055-4 · Cited by 28

Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017–2019

Adamson, P. C., Le, H. V., Le, H. H. L., Giang, L. M., Trung, N. V., & Klausner, J. D. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05532-3 · Cited by 27

Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea

Haese, E. C., Thai, V. C., & Kahler, C. M. (2021) · Vaccines · doi:10.3390/vaccines9070804 · Cited by 27

Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018

Sawatzky, P., Demczuk, W., Lefebvre, B., Allen, V. G., Diggle, M., Hoang, L., Caeseele, P. V., Haldane, D., Minion, J., Mulvey, M. R., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01688-21 · Cited by 27

Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study

Salmerón, P., Viñado, B., Arando, M., Alcoceba, E., Romero, B., Menéndez, B., Bernal, S., Idígoras, P., Colomina, J., Martín‐Saco, G., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab037 · Cited by 23

The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment

Fifer, H., & Johnson, A. P. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf109 · Cited by 22

Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions

Radovanovic, M., Kekić, D., Jovićević, M., Kabić, J., Gajić, I., Opavski, N., & Ranin, L. T. (2022) · Pathogens · doi:10.3390/pathogens11111230 · Cited by 22

Australian Gonococcal Surveillance Programme Annual Report, 2023

National Neisseria Network, A., Lahra, M. M., van Hal, S. J., & Hogan, T. R. (2025) · Communicable Diseases Intelligence · doi:10.33321/cdi.2025.49.007 · Cited by 22

Antimicrobial susceptibility of Neisseria gonorrhoeae in Barcelona during a five-year period, 2013 to 2017

Salmerón, P., Viñado, B., Ouazzani, R. E., Hernández, M., Barberà, M. J., Alberny, M., Jané, M., Larrosa, N., Pumarola, T., Hoyos-Mallecot, Y., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.42.1900576 · Cited by 22

The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae

Tickner, J. A., Lahra, M. M., & Whiley, D. M. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00520-5 · Cited by 21

Typing of Neisseria gonorrhoeae Isolates in Shenzhen, China, from 2014 to 2018 Reveals the Shift of Genotypes Significantly Associated with Antimicrobial Resistance

Li, Y., Li, Y., Xiu, L., Zeng, Y., Zhang, C., Sun, L., Zhang, L., Wang, F., & Peng, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02311-20 · Cited by 20

Hydrogel Droplet Microarray for Genotyping Antimicrobial Resistance Determinants in Neisseria gonorrhoeae Isolates

Shaskolskiy, B. L., Kandinov, I., Kravtsov, D., Vinokurova, A., Gorshkova, S., Filippova, M. A., Kubanov, A. A., Соломка, В. С., Deryabin, D. G., Dementieva, E., et al. (2021) · Polymers · doi:10.3390/polym13223889 · Cited by 19

Deciphering the Impact of Bystander Selection for Antibiotic Resistance in Neisseria gonorrhoeae

Olesen, S. W., & Grad, Y. H. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz156 · Cited by 19

Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20

Kakooza, F., Golparian, D., Matoga, M., Maseko, V., Lamorde, M., Krysiak, R., Manabe, Y., Chen, J. S., Kularatne, R. S., Jacobsson, S., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad193 · Cited by 18

Genomic epidemiology of Neisseria gonorrhoeae in Shenzhen, China, during 2019–2020: increased spread of ceftriaxone-resistant isolates brings insights for strengthening public health responses

Wang, D., Li, Y., Zhang, C., Zeng, Y., Peng, J., & Wang, F. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01728-23 · Cited by 17

Australian Gonococcal Surveillance Programme Annual Report, 2022

Lahra, M. M., van Hal, S. J., & Hogan, T. R. (2023) · Communicable Diseases Intelligence · doi:10.33321/cdi.2023.47.45 · Cited by 17

Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018

Golparian, D., Kittiyaowamarn, R., Paopang, P., Sangprasert, P., Sirivongrangson, P., Franceschi, F. J., Jacobsson, S., Wi, T., & Unemo, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac158 · Cited by 17

Emergence and dissemination of three mild outbreaks ofNeisseria gonorrhoeaewith high-level resistance to azithromycin in Barcelona, 2016–18

Salmerón, P., MORENO, A. J., Trejo-Zahínos, J., Amado, R. B., Viñado, B., Cornejo-Sánchez, T., Alberny, M., Barberà, M. J., Arando, M., Pumarola, T., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa536 · Cited by 17

Australian Gonococcal Surveillance Programme Annual Report, 2018

Lahra, M. M., Enriquez, R. P., & George, C. R. R. (2020) · Communicable Diseases Intelligence · doi:10.33321/cdi.2020.44.4 · Cited by 16

Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins

Gulati, S., Schoenhofen, I. C., Lindhout, T., Lewis, L. A., Moustafa, I. Y., Saha, S., Zheng, B., Nowak, N., Rice, P. A., Varki, A. P., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa438 · Cited by 16

Antimicrobial activity of enacyloxin IIa and gladiolin against the urogenital pathogens Neisseria gonorrhoeae and Ureaplasma spp

Heath, N. L., Rowlands, R. S., Webster, G., Mahenthiralingam, E., & Beeton, M. L. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14858 · Cited by 16

A Screen of Natural Product Extracts Identifies Moenomycin as a Potent Antigonococcal Agent

Yarlagadda, V., Rao, V. N., Kaur, M., Guitor, A. K., & Wright, G. D. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00040 · Cited by 16

Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: a global, systematic review, 1 January 2012 to 27 September 2020

Medland, N., Zhang, Y., Gunaratnam, P. J., Lewis, D. A., Donovan, B. J., Whiley, D. M., Guy, R., & Kaldor, J. M. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.18.2100917 · Cited by 15

High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024

Jacobsson, S., Cherdtrakulkiat, T., Golparian, D., Heng, L. S., Hoffman, I., Jamoralin, M. C., Kakooza, F., Kittiyaowamarn, R., Kyambadde, P., Làn, P. T., et al. (2025) · IJID Regions · doi:10.1016/j.ijregi.2025.100624 · Cited by 14

Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019

Gianecini, R., Poklépovich, T., Golparian, D., Cuenca, N., Tuduri, E., Unemo, M., Campos, J., Galarza, P. G., & Gonococcal Antimicrobial Susceptibility Surveillance Programme—Argentina1 (2021) · Emerging infectious diseases · doi:10.3201/eid2709.204843 · Cited by 14

Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol

Seib, K. L., Donovan, B. J., Thng, C., Lewis, D. A., McNulty, A. M., Fairley, C. K., Yeung, B., Jin, F., Fraser, D., Bavinton, B. R., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081675 · Cited by 14

In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions

David, A., Golparian, D., Jacobsson, S., Stratton, C. M., Lan, P. T., Shimuta, K., Sonnenberg, P., Field, N. M., Ohnishi, M., Davies, C., et al. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae217 · Cited by 14

Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia

Taouk, M. L., Taiaroa, G., Duchêne, S., Low, S. J., Higgs, C. K., Lee, D. Y. J., Pasricha, S., Higgins, N., Ingle, D. J., Howden, B. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52343-0 · Cited by 14

Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand

Nokchan, N., Wongsurawat, T., Jenjaroenpun, P., Nitayanon, P., & Tribuddharat, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271657 · Cited by 14

Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019

Aniskevich, A., Shimanskaya, I. G., Boiko, I., Golubovskaya, T., Golparian, D., Stanislavova, I. N., Jacobsson, S., Adaskevich, A., & Unemo, M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06184-7 · Cited by 14

Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study

Maatouk, I., Vumbugwa, P., Cherdtrakulkiat, T., Heng, L. S., Hoffman, I., Palaypayon, N. S., Kakooza, F., Kittiyaowamarn, R., Kyambadde, P., Lahra, M. M., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101663 · Cited by 13

Antimicrobial Resistance And Molecular Characteristics Among Neisseria gonorrhoeae Clinical Isolates In A Chinese Tertiary Hospital

Zhou, Z., Liu, L., Shen, X., Yu, J., Chen, L., Zhan, L., Chen, H., Lin, C., Jiang, Y., Hong, X., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s221109 · Cited by 13

Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study

Yaesoubi, R., Cohen, T., Hsu, K., Gift, T. L., Chesson, H. W., Salomon, J. A., & Grad, Y. H. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003077 · Cited by 13

Therapeutic CMP-Nonulosonates against Multidrug-Resistant Neisseria gonorrhoeae

Gulati, S., Schoenhofen, I. C., Lindhout, T., Schur, M. J., Landig, C. S., Saha, S., Deng, L., Lewis, L. A., Zheng, B., Varki, A. P., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901398 · Cited by 13

Is there an association between previous infection withNeisseria gonorrhoeaeand gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015–2019

Allen, H., Merrick, R., Ivanov, Z., Pitt, R., Mohammed, H. P., Sinka, K., Hughes, G., Fifer, H., & Cole, M. J. (2022) · Sexually Transmitted Infections · doi:10.1136/sextrans-2021-055298 · Cited by 12

Local emergence and global evolution of Neisseria gonorrhoeae with high-level resistance to azithromycin

Melendez, J. H., Edwards, V. L., Tirado, A. M., Hardick, J. P., Mehta, A., Aluvathingal, J., D’Mello, A., Gaydos, C. A., Manabe, Y. C., & Tettelin, H. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00927-24 · Cited by 12

First National Genomic Epidemiological Study of Neisseria gonorrhoeae Strains Spreading Across Sweden in 2016

Hadad, R., Golparian, D., Veličko, I., Ohlsson, A.-K., Lindroth, Y., Ericson, E.-L., Fredlund, H., Engstrand, L. G., & Unemo, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.820998 · Cited by 12

Experimental Urethral Infection with Neisseria gonorrhoeae

Waltmann, A., Duncan, J. A., Pier, G. B., Cywes‐Bentley, C., Cohen, M. S., & Hobbs, M. M. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_250 · Cited by 12

Identification of ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone and isolates harboring a novel mosaic penA gene in Chengdu in 2019–2020

Wang, D., Wang, Y., Li, Y., Xiu, L., Yong, G., Yang, Y., Gu, W., & Peng, J. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00614-x · Cited by 12

Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model

Jacobsson, S., Golparian, D., Oxelbark, J., Kong, F. Y. S., da Costa, R. M. A., Franceschi, F. J., Brown, D. L., Louie, A., Drusano, G. L., & Unemo, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1291885 · Cited by 12

Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017

Karymbaeva, S. T., Boiko, I., Jacobsson, S., Mamaeva, G., Ibraeva, A., Usupova, D., Golparian, D., & Unemo, M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06262-w · Cited by 11

Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections

Williams, E., Fairley, C. K., & Williamson, D. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000793 · Cited by 11

Neisseria gonorrhoeae antimicrobial susceptibility trends in Bangkok, Thailand, 2015–21: Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Kittiyaowamarn, R., Girdthep, N., Cherdtrakulkiat, T., Sangprasert, P., Tongtoyai, J., Weston, E. J., Borisov, A. S., Dunne, E. F., Chinhiran, K., Woodring, J., et al. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad139 · Cited by 10

Australian Gonococcal Surveillance Programme Annual Report, 2024

Lahra, M. M., Hurley, S. M., van Hal, S. J., & Hogan, T. A. (2025) · Communicable Diseases Intelligence · doi:10.33321/cdi.2025.49.056 · Cited by 10

Evolution and rise of antimicrobial resistance in key public health bacteria within and across the One Health sectors

Izydorczyk, C., & Church, D. L. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2633088 · Cited by 11

What’s left in the cupboard? Older antimicrobials for treating gonorrhoea

Fifer, H., Livermore, D. M., Uthayakumaran, T., Woodford, N., & Cole, M. J. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa559 · Cited by 10

A Loop-Mediated Isothermal Amplification Assay Targeting Neisseria gonorrhoeae penA -60.001

Shimuta, K., Nakayama, S., Takahashi, H., & Ohnishi, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01663-19 · Cited by 10

Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study

Unemo, M., Golparian, D., Elango, V., Bettiol, E., Piddock, L. J. V., Srinivasan, S., Bradford, P. A., Moussa, S. H., McLeod, S. M., Mueller, J. P., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101270 · Cited by 9

Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility

Ayfan, A. K. S., Macdonald, J., Irwin, A., Zowawi, H. M., Forde, B. M., Paterson, D. L., Lahra, M. M., & Whiley, D. M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac242 · Cited by 9

Characterization of 2 Neisseria gonorrhoeae Strains With High-Level Azithromycin Resistance Isolated in 2015 and 2018 in Japan

Shimuta, K., Lee, K., Yasuda, M., Furubayashi, K., Uchida, C., Nakayama, S., Takahashi, H., & Ohnishi, M. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001303 · Cited by 9

Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia

Duan, Q., Carmody, C., Donovan, B. J., Guy, R., Hui, B. B., Kaldor, J. M., Lahra, M. M., Law, M. G., Lewis, D. A., Maley, M. W., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009385 · Cited by 9

Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing

Golparian, D., Pleininger, S., Jacobsson, S., Indra, A., & Unemo, M. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.00744-22 · Cited by 8

High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae

Jacobsson, S., Mason, C., Khan, N., Meo, P., & Unemo, M. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa322 · Cited by 8

High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–24

Ahlstrand, J., Maatouk, I., Doanh, L. H., Girdthep, N., Golparian, D., Heng, L. S., Hoffman, I., Jamoralin, M. C., Kakooza, F., Kittiyaowamarn, R., et al. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf452 · Cited by 7

Addressing Sexually Transmitted Infections Due to Neisseria gonorrhoeae in the Present and Future

Pérez, J. C., Villarino, R.-A., Lago, A. D., Castellano, M. M. T., Bernal, M. L. P. D. M., Poza, S. S., & Torres-Sangiao, E. (2024) · Microorganisms · doi:10.3390/microorganisms12050884 · Cited by 7

Direct sequencing technologies for bacterial sexually transmitted infections

Jennison, A. V., Pasricha, S., & Azzato, F. (2024) · Microbiology Australia · doi:10.1071/ma24033 · Cited by 7

Bioinformatics tools used for whole-genome sequencing analysis of Neisseria gonorrhoeae: a literature review

Singh, R., KUSALIK, A. J., & Dillon, J. R. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab028 · Cited by 7

Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017

Banhart, S., Jansen, K., Buder, S. C., Tamminga, T., Calvignac‐Spencer, S., Pilz, T., Martini, A., Dudareva, S., Nikisins, S., Dehmel, K., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.41.1900648 · Cited by 7

The risk of resistance: what are the major antimicrobial resistance threats facing Australia?

Williamson, D. A., Howden, B. P., & Paterson, D. L. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50249 · Cited by 6

A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at PathogenwatchPreprint

Sánchez-Busó, L., Yeats, C., Taylor, B., Goater, R., Underwood, A. P., Abudahab, K., Argimón, S., Ma, K. C., Mortimer, T. D., Golparian, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.03.186726 · Cited by 6

Genome‐based epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Spain: A prospective multicentre study

Salmerón, P., Buckley, C., Arando, M., Alcoceba, E., Romero, B., Clavo, P., Whiley, D. M., & Serra-Pladevall, J. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19458 · Cited by 4

Association between city-level sociodemographic and health factors and the prevalence of antimicrobial-resistant gonorrhea in the US, 2000–2019: a spatial–temporal modeling study

Li, J., Murray‐Watson, R. E., Cyr, S. B. S., Grad, Y. H., Warren, J. L., & Yaesoubi, R. (2025) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2025.101006 · Cited by 3

Emergence of Neisseria gonorrhoeae Clone with Reduced Susceptibility to Sitafloxacin in China: An In Vitro and Genomic Study

Ye, M., Yao, L., Lu, X., Ding, F., Zou, D., Tian, T., Lin, Y., Ning, Z., Jiang, J., & Zhou, P. (2024) · Antibiotics · doi:10.3390/antibiotics13050468 · Cited by 3

Therapeutic potential of botanical drugs and their metabolites in the treatment of pelvic inflammatory disease

Zhong, H.-Z., Yan, P.-J., Gao, Q., Wu, J., Ji, X., & Wei, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1545917 · Cited by 3

Large Increase in Azithromycin-Resistant Neisseria gonorrhoeae in Northern Spain

Carballo, R., Povoa, M. C., Abad, R., Navarro, C., Martin, E., Álvarez-Fernández, M., Salgado‐Barreira, Á., & Potel, C. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0594 · Cited by 2

Complete Genome Sequence of Ceftriaxone-Resistant Neisseria gonorrhoeae SS3160, Isolated in Tokyo, Japan

Miyake, H., Mitobe, M., Kubota, H., Takano, H., Yokoyama, K., & Sadamasu, K. (2020) · Microbiology Resource Announcements · doi:10.1128/mra.00886-20 · Cited by 2

Antimicrobial susceptibility testing and molecular characterization of Neisseria gonorrhoeae in Tehran, Iran

Zolfaghari, P., Emamie, A. D., Rajabpour, M., Zarei, A., Whiley, D. M., Pourmand, M. R., & Pourmand, G. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624221091746 · Cited by 2

Susceptibilidad antibiótica y caracterización genotípica de aislados de Neisseria gonorrhoeae circulantes en la Comunidad Valenciana (España): proyecto GONOvig

Bolufer, A. B. F., Ferrando, F. B., Ortega, D. N., & Rodríguez, J. C. (2022) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2022.08.004 · Cited by 2

Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services

World Health Organization (2024) · doi:10.2471/b09099 · Cited by 1

Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of Neisseria gonorrhoeae predominate in Western Australia

Suwayyid, B. A. A., Haese, E. C., Mowlaboccus, S., Pearson, J. C., Whiley, D. M., Armstrong, P., Giele, C. M., Mak, D. B., Bastian, L. D., Wise, M. J., et al. (2023) · Microbial Genomics · doi:10.1099/mgen.0.000969 · Cited by 1

Novel potential treatment options for infections caused by multi-drug and extensively drug-resistant Neisseria gonorrhoeae strains

Jacobsson, S., & Unemo, M. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2733617 · Cited by 1

Australian Gonococcal Surveillance Programme Annual Report, 2025

Hogan, T. R., & Lahra, M. M. (2026) · Communicable Diseases Intelligence · doi:10.33321/cdi.2026.50.057 · Cited by 1

High rate of fluoroquinolone resistant Neisseria gonorrhoeae detected by molecular surveillance of antimicrobial resistance determinants in Bulgaria

Philipova, I. O., Levterova, V., Simeonovski, I., & Kantardjiev, T. (2022) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2022.2146532 · Cited by 1

Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018

Eyre, D. W., Town, K., Street, T. L., Barker, L., Sanderson, N. D., Cole, M. J., Mohammed, H. P., Pitt, R., Gobin, M., Irish, C., et al. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.10.1900147 · Cited by 132

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

Eyre, D. W., Sanderson, N. D., Lord, E., Regisford-Reimmer, N., Chau, K., Barker, L., Morgan, M., Newnham, R. S., Golparian, D., Unemo, M., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.27.1800323 · Cited by 345

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022

Pleininger, S., Indra, A., Golparian, D., Heger, F., Schindler, S., Jacobsson, S., Heidler, S., & Unemo, M. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.24.2200455 · Cited by 106

Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023

Maubaret, C., Caméléna, F., Mrimèche, M., Braille, A., Liberge, M., Mainardis, M., Guillaume, C., Noël, F., Bébéar, C., Molina, J., et al. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.37.2300456 · Cited by 51

Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017–2018

Yuan, Q., Li, Y., Xiu, L., Zhang, C., Fu, Y., Jiang, C., Tang, L., & Peng, J. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1681242 · Cited by 52